Company Filing History:
1 out of 1 
1 out of 4 
1 out of 1 Years Active: 2020-2025
Title: Wenshan Hao: Innovator in Biopharmaceuticals
Introduction
Wenshan Hao is a notable inventor based in Parsippany, NJ (US). He has made significant contributions to the field of biopharmaceuticals, holding a total of 3 patents. His work focuses on innovative therapies that address critical health challenges.
Latest Patents
One of Wenshan Hao's latest patents is titled "Chimeric antigen receptor comprising BCMA nanobody linked to a chimeric intracellular signaling domain." This application relates to functionally improved third generation BCMA-CARs, which comprise modified intracellular co-stimulatory domains. These advancements can be utilized in adoptive cell therapy, particularly in the treatment of diseases and disorders such as cancer. Another significant patent is for "Substituted imidazo[1,2-a]pyridin-2-ylamine compounds, and pharmaceutical compositions and methods of use thereof." This patent provides substituted imidazo[1,2-a]pyridin-2-ylamine compounds and pharmaceutical compositions, along with methods for treating, preventing, or ameliorating symptoms of Janus kinase-mediated diseases.
Career Highlights
Wenshan Hao has worked with several prominent companies in the biopharmaceutical sector. Notably, he has been associated with Neomics Pharmaceuticals LLC and Shanghai Fudan-Zhangjiang Bio-pharmaceutical Co., Ltd. His expertise and innovative approach have made him a valuable asset in these organizations.
Collaborations
Throughout his career, Wenshan has collaborated with talented individuals, including Jin Li and Sean Chen. These partnerships have contributed to the advancement of his research and the successful development of his patented technologies.
Conclusion
Wenshan Hao's contributions to biopharmaceutical innovations are noteworthy. His patents reflect a commitment to improving therapeutic options for patients facing serious health conditions. His work continues to inspire advancements in the field.